本页面由Tiger Trade Technology Pte. Ltd.提供服务

Mersana Therapeutics Inc.

29.08
0.0000
成交量:- -
成交额:2,077.17万
市值:1.45亿
市盈率:-2.06
高:29.08
开:29.08
低:29.08
收:29.08
52周最高:36.25
52周最低:5.21
股本:499.88万
流通股本:375.34万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-14.0861
每股收益(LYR):-14.1163
净资产收益率:-505.14%
总资产收益率:-36.27%
市净率:-2.44
市盈率(LYR):-2.06

数据加载中...

2021/08/06

重要事件披露

8-K - Current report
2021/06/17

重要事件披露

8-K - Current report
2021/05/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/04/09

重要事件披露

8-K - Current report
2021/03/11

重要事件披露

8-K - Current report
2021/02/26

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/26

重要事件披露

8-K - Current report
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/27

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/05

重要事件披露

8-K - Current report
2020/12/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/30

重要事件披露

8-K - Current report
2020/11/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership